Literature DB >> 16247608

Occurrence of bicuculline-, NMDA- and kainic acid-induced seizures in prenatally methamphetamine-exposed adult male rats.

Romana Slamberová1, R Rokyta.   

Abstract

Stimulant drugs are often associated with increased seizure susceptibility. Inhibitory gamma-aminobutyric acid (GABA) and excitatory N-methyl-D-aspartate (NMDA) systems play an important role in the effect of stimulants on epileptic seizures. No studies investigating the effect of prenatal methamphetamine (MA) exposure on seizures are available. In this study, bicuculline (GABAA receptor antagonist), NMDA (NMDA receptor agonist) and kainic acid (non-NMDA receptor agonist) were used to induce seizures in adult male rats. Three groups of animals were tested in each seizure test: prenatally MA- (5 mg/kg) exposed, prenatally saline-exposed, and absolute controls without any prenatal exposure. In bicuculline-induced seizures, the latency to onset of tonic-clonic seizures was shorter in MA-exposed rats than in controls, but it did not differ from saline-exposed rats. There were no differences in clonic seizure onset between groups. In NMDA-induced seizures, the latency to onset of clonic-tonic seizures was shorter in prenatally MA-exposed rats than in controls; however, the latency to onset of saline-exposed animals did not differ from either MA-exposed or from control rats. There were no differences in seizure susceptibility in kainic acid-induced clonic seizures. There were no differences in seizure incidences or stereotypical behavior in any seizure model. The question remains as to how much the present data demonstrate the effect of prenatal drug exposure on seizure susceptibility per se, and how much they may be explained by the effect of prenatal stress or by other mechanism(s).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247608     DOI: 10.1007/s00210-005-0016-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine.

Authors:  A J Eisch; S J O'Dell; J F Marshall
Journal:  Synapse       Date:  1996-03       Impact factor: 2.562

2.  Prenatal morphine exposure alters N-methyl-D-aspartate- and kainate-induced seizures in adult male rats.

Authors:  R Slamberová; L Velísek; I Vathy
Journal:  Pharmacol Biochem Behav       Date:  2000-01-01       Impact factor: 3.533

Review 3.  Excitatory amino acid receptors and synaptic plasticity.

Authors:  G L Collingridge; W Singer
Journal:  Trends Pharmacol Sci       Date:  1990-07       Impact factor: 14.819

4.  Postnatal development of rat pups is altered by prenatal methamphetamine exposure.

Authors:  Romana Slamberová; Marie Pometlová; Petra Charousová
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07-19       Impact factor: 5.067

5.  Prenatal maternal d-amphetamine effects on emotionality and audiogenic seizure susceptibility of rat offspring.

Authors:  D L Seliger
Journal:  Dev Psychobiol       Date:  1975-05       Impact factor: 3.038

6.  Learning in the Place navigation task, not the New-learning task, is altered by prenatal methamphetamine exposure.

Authors:  Romana Slamberová; Marie Pometlová; Lýdia Syllabová; Magdaléna Mancusková
Journal:  Brain Res Dev Brain Res       Date:  2005-06-30

7.  Expression of long-term potentiation of the striatum in methamphetamine-sensitized rats.

Authors:  T Nishioku; T Shimazoe; Y Yamamoto; H Nakanishi; S Watanabe
Journal:  Neurosci Lett       Date:  1999-06-18       Impact factor: 3.046

8.  Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality.

Authors:  Danielle Silveira Macêdo; Rachel S Santos; Luciana D Belchior; Manoel Andrade Neto; Silvânia Maria Mendes Vasconcelos; Vera Targino Moreira Lima; Marta Maria França Fonteles; Glauce Socorro Barros Viana; Francisca Cléa Florenço de Sousa
Journal:  Epilepsy Behav       Date:  2004-12       Impact factor: 2.937

9.  Kainate-induced status epilepticus alters glutamate and GABAA receptor gene expression in adult rat hippocampus: an in situ hybridization study.

Authors:  L K Friedman; D E Pellegrini-Giampietro; E F Sperber; M V Bennett; S L Moshé; R S Zukin
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

10.  Field-specific changes in hippocampal opioid mRNA, peptides, and receptors due to prenatal morphine exposure in adult male rats.

Authors:  C J Schindler; R Slamberová; A Rimanóczy; O C Hnactzuk; M A Riley; I Vathy
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  4 in total

1.  Epileptic seizures increase circulating endothelial cells in peripheral blood as early indicators of cerebral vascular damage.

Authors:  Helena Parfenova; Charles W Leffler; Dilyara Tcheranova; Shyamali Basuroy; Aliz Zimmermann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

2.  Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.

Authors:  Devon L Graham; Robyn M Amos-Kroohs; Amanda A Braun; Curtis E Grace; Tori L Schaefer; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-06       Impact factor: 5.176

3.  Effects of a single postnatal methamphetamine administration on NMDA-induced seizures are sex- and prenatal exposure-specific.

Authors:  Romana Slamberová; Barbora Schutová; Iveta Matejovská; Klára Bernásková; Richard Rokyta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-14       Impact factor: 3.000

4.  Induction of mitochondrial permeability transition (MPT) pore opening and ROS formation as a mechanism for methamphetamine-induced mitochondrial toxicity.

Authors:  Vida Mashayekhi; Mohammad Reza Eskandari; Farzad Kobarfard; Alireza Khajeamiri; Mir-Jamal Hosseini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-24       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.